Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies

Expert Review of Pharmacoeconomics & Outcomes Research
Melissa RobertsDouglas W Mapel

Abstract

This review identifies and evaluates the comprehensive reporting of peer-reviewed economic evaluations of the effectiveness of fluticasone-propionate/salmeterol combination (FSC) therapy for maintenance treatment of chronic obstructive pulmonary disease (COPD). Economic evaluations were included if published in English since 2003. Evaluation categories included in the review were cost-effectiveness, cost-utility, and cost-consequence analyses. FSC is cost-effective in comparison to short-acting bronchodilators (SABDs). Cost and outcome differences between FSC and other long-acting therapies were modest. Studies exhibited large variations in populations, designs and environment, limiting the ability to draw conclusions. Many new maintenance treatments for COPD have been approved since 2010. Most have yet to be compared to older treatments like FSC. Evaluations are needed that consider costs and outcomes from a societal perspective (e.g., patients' ability to keep working) and evaluations that include subgroup analyses to investigate differential impacts according to clusters of patient characteristics.

References

Oct 9, 1996·JAMA : the Journal of the American Medical Association·L B RussellM C Weinstein
Oct 16, 1996·JAMA : the Journal of the American Medical Association·M C WeinsteinL B Russell
Feb 6, 1998·PharmacoEconomics·J A MauskopfA Stergachis
Apr 20, 1999·Chest·D A MahlerW H Anderson
Jun 16, 2001·Chest·B J Lipworth
Dec 12, 2002·Chest·Sven-Arne JanssonBo Lundbäck
Feb 14, 2003·Lancet·Peter CalverleyUNKNOWN TRial of Inhaled STeroids ANd long-acting beta2 agonists study group
Mar 22, 2003·Respiratory Medicine·R Dal NegroI Cerveri
Jun 11, 2003·The European Respiratory Journal. Supplement·S D Ramsey, S D Sullivan
Nov 14, 2003·Journal of Managed Care Pharmacy : JMCP·Joshua J OfmanJoel W Hay
Dec 15, 2004·Chest·Nicholas J Gross
Aug 3, 2005·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Peter J NeumannMilton C Weinstein
Nov 18, 2005·Respiratory Medicine·Jeno P MartonJoseph Menzin
Apr 20, 2006·Pulmonary Pharmacology & Therapeutics·Gustavo J Rodrigo, Luís J Nannini
Sep 12, 2006·Proceedings of the American Thoracic Society·David M G Halpin, Marc Miravitlles
Jan 18, 2007·JAMA : the Journal of the American Medical Association·Ralph B D'Agostino, Ralph B D'Agostino
Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
Apr 28, 2007·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·J Mark FitzGeraldUNKNOWN RUSIC Study Group
May 18, 2007·American Journal of Respiratory and Critical Care Medicine·Klaus F RabeUNKNOWN Global Initiative for Chronic Obstructive Lung Disease
Jan 15, 2008·Health Policy·Oya Eddama, Joanna Coast
Nov 18, 2008·Respiratory Medicine·Stephanie R EarnshawDouglas W Mapel
Jan 1, 2008·Journal of Medical Economics·Leandro Fritscher, Kenneth R Chapman
Sep 1, 2009·The European Respiratory Journal·A H BriggsUNKNOWN TOwards a Revolution in COPD Health (TORCH) investigators
Mar 31, 2010·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·David M G Halpin
May 14, 2010·American Journal of Respiratory and Critical Care Medicine·James F DonohueUNKNOWN INHANCE Study Investigators
Jun 5, 2010·American Journal of Respiratory and Critical Care Medicine·MeiLan K HanFernando J Martinez
Aug 31, 2010·PharmacoEconomics·Douglas W MapelJeno P Marton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Managed Care Pharmacy : JMCP
Daniel E Hilleman
International Journal of Chronic Obstructive Pulmonary Disease
Anand A DalalKathy Manavi-Zieverink
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Ning ShenWan-Zhen Yao
© 2021 Meta ULC. All rights reserved